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Abstract
Background: The direct bilirubin (D-Bil) assay on the AU 
Beckman Coulter instrumentation can be interfered by 
paraproteins, which may result in spurious D-Bil results. 
In a previous work, we took advantage of this fact to detect 
this interference, thus helping with the identification of 
patients with unsuspected monoclonal gammopathies. In 
this work, we investigate the possibility to detect interfer-
ence based on the review of the photometric reactions, 
regardless of the D-Bil result.
Methods: The D-Bil assay was carried out in a set of 
2164 samples. It included a group of 164 samples with para-
proteins (67 of which caused interference on the assay), 
as well as different groups of samples for which high 
absorbance background readings could also be expected 
(i.e. hemolyzed, lipemic, or icteric samples). Photometric 
reaction data were reviewed and receiver operating char-
acteristics (ROC) curves were used to establish a cut-off for 
absorbance that best discriminates interference.
Results: The best cut-off was 0.0100 for the absorbance 
at the first photometric point of the complementary wave-
length in the blank cuvette. Once the optimal cut-off for 
probable interference was selected, all samples analyzed 
in our laboratory that provided absorbance values above 
this cut-off were further investigated to try to discover 
paraproteins. During a period of 6  months, we detected 
44  samples containing paraproteins, five of which 
belonged to patients with non-diagnosed monoclonal 
gammopathies.
Conclusions: Review of the photometric reaction data per-
mits the systematic detection of paraprotein interference 
on the D-Bil AU assay, even for samples for which reason-
able results are obtained.
Keywords: direct bilirubin; interference; paraprotein; 
photometric reaction.
Introduction
Paraproteins are a common cause of interference in 
routine chemistry methods [1, 2], and the direct biliru-
bin (D-Bil) AU Beckman Coulter assay seems to be par-
ticularly sensitive to this interference [3–6]. This test is a 
two-cuvette (blank and color) endpoint assay based on 
the formation of azobilirubin [by reaction of conjugated 
(direct) bilirubin from the serum sample with a diazonium 
salt at low pH], which is then measured bichromatically 
at 570/660  nm. To  this end, the patient’s serum is first 
incubated with hydrochloric and sulfuric acids (reagent 
1) in both cuvettes. Then, 3,5-dichlorophenyldiazonium 
tetrafluoroborate (reagent 2) is added to the color cuvette 
to produce azobilirubin. Finally, the blank cuvette absorb-
ance is subtracted from the color cuvette absorbance to 
determine the net reaction absorbance [4, 5].
In this context, paraprotein interference is caused 
by precipitation of the particular paraprotein under the 
high acidic conditions used in the assay [3, 4], which has 
different consequences for the analytical result. First, 
absorbance of the blank cuvette does not parallel that of 
the color cuvette, and therefore, highly variable readings 
are obtained throughout the reaction [4]. Additionally, 
it has also been observed that interfered reactions often 
show very high absorbance values at the first photometric 
point in both cuvettes. Both facts may result in spurious 
D-Bil values [such as D-Bil values greater than total biliru-
bin (T-Bil) or negative/very low D-Bil values] but can also 
provide reasonable D-Bil values.
There is no clear relationship between the concentra-
tion or isotype of the paraprotein and interference, which 
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seems to be more dependent on the specific paraprotein 
than on the concentration. However, for samples of the 
same patient for which interferences were periodically 
detected, those were more prone to occur with high para-
protein concentrations only [6].
As recently described in a paper published by our 
group [6], if properly detected, this interference can be 
used to systematically detect patients with paraproteins 
who were not suspected a priori to have a monoclonal 
gammopathy, helping to advance diagnosis even for 
totally asymptomatic patients. In our previous paper, 
detection of interference relied on the Laboratory Infor-
mation System (LIS) for detecting anomalous D-Bil 
results, as the AU instruments do not allow raising flags 
based on absorbance values [4]. However, and consider-
ing that paraprotein interference may also provide rea-
sonable D-Bil results by mere chance, this protocol fails 
in detecting all paraprotein interferences and subsequent 
diagnosis of monoclonal gammopathies.
In this paper, an alternative method for detection of 
paraprotein interference on the D-Bil assay, regardless 
of the D-Bil result obtained, is investigated. This method 
is based on the revision of the photometric data, as was 
recently described for the T-Bil assay with another instru-
mentation [7].
Materials and methods
A total of 164 serum samples having paraproteins of different concen-
tration (confirmed by immunofixation) were subjected to four rep-
licate D-Bil measurements on the AU analyzers (Beckman Coulter, 
Brea, CA, USA). Interference was suspected when high relative stand-
ard deviation (RSD) values, together with one or more spurious D-Bil 
results (negative D-Bil, D-Bil above T-Bil) were obtained for any of 
the replicate measurements (see Table 1 for examples on interference 
identification). In any case, and to avoid misclassification of samples 
with D-Bil results close to the limit of detection (0.14 mg/L) for which 
fairly large %RSD can be obtained, the presence of interference was 
finally confirmed for all samples with paraproteins by detection of 
turbidity after visual inspection of the reaction carried out manually, 
as described by Nauti et al. [3]. Note that in Table 1 we have included 
the actual value obtained for each replicate (even if it was below the 
limit of detection of 0.14 mg/L), to illustrate the variability of results 
that can be obtained for these kinds of samples.
A total of 67 samples interfered the assay and were considered to 
be true positives (group 1). The remaining 97 samples containing para-
proteins did not show interference and were considered true negatives 
(group 2). For comparison purposes, 2000 samples without parapro-
teins were also analyzed, including samples for which high absorb-
ance background readings could also be expected (i.e. hemolyzed 
or lipemic samples). The samples analyzed included, in particular, 
200  samples with hemolysis (group 3), 100  samples with lipemia 
(group 4), 100 samples with icterus (group 5) and 1600 samples free 
from hemolysis, lipemia, and icterus (group 6). These serum indexes 
were determined by routine photometric measurements.
Photometric data for all D-Bil reactions carried out in that set 
of samples were manually reviewed looking for an absorbance cut-
off that best identifies the paraprotein interference. For this purpose, 
the first photometric point acquired in both cuvettes was evaluated 
at the different wavelengths available: 570 and 660 nm for the blank 
cuvette and 660 nm for the color cuvette. The absorbance at 570 nm 
in the color cuvette cannot be used for this purpose as it depends 
on the sample D-Bil concentration. Table 2 displays the descriptive 
statistics obtained for each sample group considered, and Figure 1 
shows the same data graphically (for the 660-nm blank cuvette). Sig-
nificant differences for the absorbance values were found between 
group 1 (interfering paraproteins) and the rest of the sample groups 
considered, which was proved by the corresponding Kruskal–Wallis 
test (p < 0.01 for all three wavelengths).
At a later stage, receiver operating characteristics (ROC) curves 
were used to establish the desired cut-off value. The process was 
repeated three times: (a) only with samples containing parapro-
teins (i.e. groups 1 and 2; population A), (b) with all sample groups 
(population B) and c) with all samples excluding those with hemoly-
sis, icterus, and lipemia (i.e. groups 1, 2, and 6; population C). ROC 
curves were calculated with MedCalc (MedCalc Software BVBA, 
 version 16.2.1, Ostend, Belgium) and compared using the method of 
DeLong et al. [8].
Once the optimal cut-off for probable interference was selected, 
all D-Bil reactions carried out in our laboratory during a period of 
6 months (July–December 2015) were inspected, and those providing 
absorbance values above the cut-off were further investigated to try 
to discover paraproteins. Figure 2 is a graphical representation of this 
protocol.
The Hospital Universitario Miguel Servet (HUMS) Ethics 
 Committee approved the study.
Results
Table 3 collects the results of the diagnostic efficiency 
parameters evaluated by ROC curves. As expected, the 
area under the curve (AUC) and the best possible cut-off 
depend on the population considered. There are not sta-
tistically significant differences between using 570  and 
660 nm in the blank cuvette. This applies also to 660 nm 
in the color cuvette, except for population B. This set of 
samples includes an important percentage of hemolyzed 
or lipemic samples (the majority of false positives). In this 
case, a better diagnostic efficiency is obtained using the 
blank cuvette.
The final decision to monitor the absorbance at 570 or 
660 nm in the blank cuvette was based on convenience. It 
has to be kept in mind that the cut-off value must be man-
ually checked on the instrument display for each reac-
tion carried out, and in this context, a round figure such 
as 0.0100 is much easier to visually identify. As shown in 
Table 3, the optimal cut-offs for populations A and B in 
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the blank cuvette at 660 nm are much closer to this round 
figure than those at 570  nm, and hence, we decided to 
use the cut-off at 660 nm in the blank cuvette for further 
studies. Table 4 shows the diagnostic efficiency reached 
with this cut-off.
After the method was setup and during a period of 
6 months, 15,181 D-Bil determinations were carried out in 
our laboratory and the corresponding photometric reac-
tions were inspected, providing 331 measurements above 
the absorbance cut-off (see examples in Table 5); most 
of those measurements corresponded to samples with 
lipemia (85) or with intense hemolysis (186) and 53 were 
from patients already known to contain paraproteins or 
polyclonal immunoglobulins of elevated concentration. 
Finally, seven samples were further assayed to investi-
gate the presence of paraproteins by immunoglobulin 
quantification, protein electrophoresis, and if necessary, 
immunofixation. In five of these samples, the presence 
of a paraprotein was confirmed, one showed elevated 
polyclonal immunoglobulins, and the remaining one did 
not show any altered parameter. The absorbance for this 
sample (sample 7 in Table 5) was just above the cut-off, 
and it is possible that, although not detected by the cor-
responding serum index measurement, it could be slightly 
lipemic.
Discussion
The presence of paraproteins may interfere with the D-Bil 
AU assay, and if it is properly detected, this interference 
may uncover non-diagnosed monoclonal gammopathies 
[6]. In this work we describe the protocol developed in our 
laboratory to detect this interference based on the obser-
vation that it often results in anomalous absorbance pat-
terns. As the AU software does not automatically permit 
the raising of flags on photometric data, we developed 
a method based on manual revision of the absorbance 
values.
As explained in detail in the Materials and methods 
section, the best discriminating approach was based on 
selection of the optimal cut-off for the absorbance at the 
first photometric point in the blank cuvette. A great per-
centage of the samples analyzed in our laboratory on a 
daily basis belongs to newborns and are often hemolyzed. 
As a result, our typical set of samples would resemble 
population B in terms of false positives. For this popula-
tion, the optimal cut-offs for the blank cuvette are 0.0102 
and 0.0158 at 660 and 570 nm, respectively, and selection 
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Figure 1: Absorbance values obtained at 660 nm in the blank cuvette (first photometric point) for the different sample groups considered.a
For the sake of readability, these values are multiplied by 10,000 and log transformed. aGroup 1: 67 samples containing paraproteins 
interfering with D-Bil Beckman AU assay; Group 2: 97 samples containing paraproteins not interfering with D-Bil AU assay; Group 3: 
200 hemolyzed samples without paraproteins; Group 4: 100 lipemic samples without paraproteins; Group 5: 100 icteric samples without 
paraproteins; and Group 6: 1600 samples without paraproteins and free from hemolysis, lipemia, and icterus.


















0 0.0045 0.0033 0.0012 0.0007
1 0.0550 0.0399 0.0151 0.0008
2 0.0565 0.0408 0.0157 0.0009
3 0.0580 0.0416 0.0164 0.0009
4 0.0591 0.0423 0.0168 0.0009
5 0.0597 0.0427 0.0170 0.0009
6 0.0603 0.0430 0.0173 0.0009
Reaction660 nm
Figure 2: Graphical representation of the protocol developed in our laboratory to detect unsuspected monoclonal gammopathies.
Table 3: Diagnostic efficiency values for detecting interference by paraproteins in direct bilirubin (D-Bil) assay with different population 
samples.
Populationa Cut-offb AUCc p-Valued Sensitivity Specificity
A: groups 1 and 2 1: Blank cuvette (570 nm): 0.0160 0.992 Comparison 1–2: p = 0.51 0.943 0.947
2: Blank cuvette (660 nm): 0.0099 0.993 Comparison 2–3: p = 0.11 0.955 0.947
3: Color cuvette (660 nm): 0.0104 0.986 Comparison 1–3: p = 0.12 0.920 0.916
B: groups 1–6 1: Blank cuvette (570 nm): 0.0158 0.991 Comparison 1–2: p = 0.06 0.943 0.947
2: Blank cuvette (660 nm): 0.0102 0.990 Comparison 2–3: p < 0.01e 0.943 0.937
3: Color cuvette (660 nm): 0.0121 0.979 Comparison 1–3: p < 0.01e 0.909 0.908
C: groups 1, 2, and 6 1: Blank cuvette (570 nm): 0.0116 0.999 Comparison 1–2: p = 0.45 0.989 0.988
2: Blank cuvette (660 nm): 0.0079 0.999 Comparison 2–3: p = 0.11 0.989 0.989
3: Color cuvette (660 nm): 0.0073 0.997 Comparison 1–3: p = 0.10 0.966 0.982
aSee definition of groups in legend to Figure 1. bBest cut-off for absorbance at first photometric point (570 nm, reaction wavelength; 660 nm, 
complementary wavelength. cAUC: area under the curve. d,eSignificant p-value < 0.05.
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terms of diagnostic efficiency. However, it has to be kept 
in mind that owing to the instrument limitations, photo-
metric data must be manually reviewed on the instrument 
display, and in this situation, it is much easier to visually 
identify values exceeding a round figure such as 0.0100. 
By selecting this cut-off, we decided to maximize specific-
ity while maintaining a good sensitivity (Table 4), which 
allowed us to considerably reduce the number of results 
to be reviewed.
With this working protocol and during a period or 
6 months, 15,181 D-Bil determinations were reviewed and 
44 samples interfered by paraproteins were detected; five 
of these samples corresponded to patients unsuspected 
of having a monoclonal gammopathy, while the rest were 
from patients already diagnosed with different types of 
monoclonal gammopathies, most of them followed up at 
the Hematology Department of the HUMS.
Practical implementation of the method developed 
consisted of the daily review of all of the D-Bil reactions 
carried out at the laboratory the morning after they were 
measured. Those samples with absorbance values above 
the selected cut-off were subsequently reviewed on the 
LIS to confirm whether they were samples with lipemia 
or intense hemolysis or whether they belonged to patients 
already known to contain paraproteins or elevated poly-
clonal immunoglobulins. Only samples outside these cat-
egories were further assayed to determine if a paraprotein 
was present. The whole process of reviewing the D-Bil 
photometric data and deciding which samples should 
call for additional testing only required 10–15 min of addi-
tional work.
The method developed allowed us to confirm that in 
a great percentage of the reactions, the presence of inter-
ference by paraproteins still provides totally reasonable 
D-Bil results (43% in our case). For this reason, relying 
on the LIS for flagging spurious D-Bil results only (D-Bil 
greater than the T-Bil or negative/very low D-Bil results) 
would result in many cases of monoclonal gammopathies 
not properly detected. In this particular study three out 
of the five patients first discovered to have a monoclonal 
gammopathy (samples 6 and 8 in Table 5) would have 
been missed.
Table 4: Diagnostic efficiency values for detecting interference by 
paraproteins on the D-Bil assay with different sample populations 
using 0.0100 as a cut-off for absorbance.
Populationa   Cut-off = 0.0100   Sensitivity  Specificity
A: groups 1 and 2   Blank cuvette (570 nm)  1.000  0.890
  Blank cuvette (660 nm)  0.943  0.947
  Color cuvette (660 nm)   0.932  0.908
B: groups 1–6   Blank cuvette (570 nm)  1.000  0.914
  Blank cuvette (660 nm)  0.943  0.936
  Color cuvette (660 nm)   0.932  0.888
C: groups 1, 2, and 6  Blank cuvette (570 nm)  1.000  0.986
  Blank cuvette (660 nm)  0.943  0.994
  Color cuvette (660 nm)   0.932  0.991
aSee definition of groups in legend to Figure 1.
Table 5: Examples of samples that provided reasonable direct bilirubin (D-Bil) results with absorbance readings above the selected cut-off.













570 nm  660 nm 570 nm  660 nm
1   183  6.2  0.0299  0.0207  0.0298  0.0215  Intense hemolysis. Newborn.      
2   3.4  1.0  0.3468  0.2212  0.3477  0.2210  Intense lipemia      
3   7.5  2.1  0.0353  0.0220  0.0148  0.0051  Known paraproteinemia (MGUS IgA κ)   10.0  25  0.7
4   8.2  4.7  0.2943  0.2132  0.3124  0.2227  Known paraproteinemia (MM IgG κ)   2.4  35  0.3
5   24.8  6.6  0.0229  0.0141  0.0340  0.0166  Chronic elevated polyclonal immunoglobulins  3.9  31  3.7
6   4.0  0.6  0.3110  0.2285  0.3126  0.2293  Further assayed. Monoclonal gammopathy 
IgG κ confirmed (82-year-old woman under 
evaluation. MM suspected.)
  0.7  22  0.8
7   11.4  3.0  0.0183  0.0113  0.0248  0.0141  Further assayed. Paraprotein not present.      
8   5.6  4.5  0.1321  0.0892  0.1655  0.1073  Further assayed. Monoclonal gammopathy 
IgG κ confirmed (60-year-old woman under 
evaluation).
  2.0  22  0.9
aTo convert total or direct bilirubin from mg/L to μmol/L multiply by 1.71. bAbsorbance at first photometric point. A value > 0.0100 at 660 nm 
in blank cuvette requires investigation. cFurther assayed refers to samples not hemolyzed or lipemic but suspected to contain paraproteins 
from patients unknown to have monoclonal gammopathies or elevated polyclonal immunoglobulins were further investigated. dMGUS, 
monoclonal gammopathy of undetermined significance; MM, multiple myeloma.
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Although moving from only flagging unreasonable/
non-possible D-Bil results to review all the D-Bil photo-
metric reactions has been a considerable improvement 
in the protocol set up in our laboratory, there is evidence 
that supports the conclusion that to detect all samples 
interfered by paraproteins, monitoring photometric reac-
tions for all chemistry assays would be recommended. 
In this sense, for instance, Alberti et al. [9] have recently 
reported a particular patient paraprotein precipitating at 
both extremely high and extremely low pH values, imply-
ing that all assays carried out under these conditions, spe-
cifically the D-Bil, creatinine and total protein AU assays, 
would be interfered. As the composition of each parapro-
tein is patient dependent, each sample containing a para-
protein may show a particular pH at which it aggregates, 
and therefore, the assay(s) affected for a particular patient 
can be different from those affected for other patients. As 
a result, it seems clear that the best way to maximize pos-
sibilities for interference detection would be to monitor all 
photometric reactions for all chemistry assays.
The particularities of the method presented in this 
work are a good illustration of this issue. In fact, most 
laboratories only perform the D-Bil assay when the T-Bil 
result is above the upper reference limit, and hence, the 
sole application of this method would be clearly insuffi-
cient for detecting paraproteins in most cases. In our par-
ticular study, none of the five patients discovered to have 
an unsuspected paraprotein would have been detected if 
D-Bil analysis had been only performed for samples for 
which the T-Bil result was above the upper reference limit.
Finally, it may be worth mentioning that our main 
goal with this protocol, in addition to detecting interfer-
ences that may translate into erroneous test results, was 
to discover the presence of unsuspected paraproteins. To 
systematically search for information not ordered by the 
clinician could raise ethical questions [10, 11], and the 
answers to these questions may vary depending on the 
country. However, as our laboratory is part of the public 
Spanish Health System, this fact was not really an issue in 
our case. Furthermore, all samples considered in this study 
belonged to patients whose practitioner had requested a 
blood test to assess their general health status. Therefore, 
revealing the presence of large paraproteins can only bring 
benefits to the patient, even though the clinician had not 
specifically requested such tests. For patients presenting 
with paraproteins, it is of paramount importance to begin 
evaluation and/or treatment (if required) as early as pos-
sible, especially considering that most of the patients 
exhibiting this interference present paraproteins of high 
concentration [6]. Even if asymptomatic, these patients 
should be checked periodically, especially considering 
that annual progression to malignancy for monoclonal 
gammopathy of undetermined significance (MGUS) is as 
high as 1% [12].
Conclusions
We have demonstrated that reviewing the D-Bil photomet-
ric data is a valuable strategy that serves to systematically 
detect interference by paraproteins on the D-Bil AU assay, 
regardless of the particular D-Bil result. However, the AU 
software requires that each reaction be manually reviewed 
on the instrument display, without the possibility of auto-
matically flagging anomalous absorbance patterns.
As paraproteins are patient-dependent, and each 
specific paraprotein may precipitate at a particular pH, 
different assays may be affected for different patients. 
Therefore, all chemistry reactions should be monitored to 
try to detect interference in all samples, maximizing the 
possibilities to diagnose monoclonal gammopathies. This 
will only be possible when current instrumentation is sup-
plied with an automated flagging system that would allow 
monitoring the tens of thousands of reactions carried out 
at clinical laboratories on a daily basis.
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